$6.65
1.37% yesterday
Nasdaq, Nov 25, 10:00 pm CET
ISIN
US2290503075
Symbol
CYRX

CryoPort Stock price

$6.65
-0.24 3.48% 1M
-4.39 39.76% 6M
-8.84 57.07% YTD
-7.49 52.97% 1Y
-61.97 90.31% 3Y
-8.31 55.55% 5Y
+1.01 17.91% 10Y
Nasdaq, Closing price Mon, Nov 25 2024
+0.09 1.37%
ISIN
US2290503075
Symbol
CYRX
Industry

Key metrics

Market capitalization $328.71m
Enterprise Value $321.69m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 1.42
P/S ratio (TTM) P/S ratio 1.45
P/B ratio (TTM) P/B ratio 0.85
Revenue growth (TTM) Revenue growth -4.33%
Revenue (TTM) Revenue $226.11m
EBIT (operating result TTM) EBIT $-71.58m
Free Cash Flow (TTM) Free Cash Flow $-27.14m
Cash position $272.67m
EPS (TTM) EPS $-3.39
P/E forward negative
P/S forward 1.44
EV/Sales forward 1.41
Short interest 7.08%
Show more

Is CryoPort a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

CryoPort Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a CryoPort forecast:

3x Buy
33%
6x Hold
67%

Analyst Opinions

9 Analysts have issued a CryoPort forecast:

Buy
33%
Hold
67%

Financial data from CryoPort

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
226 226
4% 4%
100%
- Direct Costs 148 148
1% 1%
65%
78 78
10% 10%
35%
- Selling and Administrative Expenses 101 101
10% 10%
45%
- Research and Development Expense 18 18
2% 2%
8%
-41 -41
78% 78%
-18%
- Depreciation and Amortization 30 30
16% 16%
13%
EBIT (Operating Income) EBIT -72 -72
45% 45%
-32%
Net Profit -158 -158
240% 240%
-70%

In millions USD.

Don't miss a Thing! We will send you all news about CryoPort directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

CryoPort Stock News

Negative
Seeking Alpha
one day ago
Cryoport operates in the promising life sciences sector but continues to suffer from poor fundamentals and significant cash flow challenges. Despite slight revenue growth in Q3 2024, the company remains unprofitable and has seen a drastic share price decline since my initial 'sell' rating. Recent financial improvements are minimal, with net losses narrowing and cash flow turning slightly positi...
Neutral
PRNewsWire
14 days ago
Facility Dedicated to Cryopreservation of Leukapheresis Starting Materials to Support Clinical and Commercial Cell-Based Therapy Programs NASHVILLE, Tenn. , Nov. 12, 2024 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in supply chain solutions for the life sciences industry, today announced the opening of its newest IntegriCell™ facility in Villers-...
Neutral
Seeking Alpha
17 days ago
Cryoport, Inc. (NASDAQ:CYRX ) Q3 2024 Earnings Conference Call November 7, 2024 5:00 PM ET Company Participants Todd Fromer - Investor Relations, KCSA Strategic Communications Jerrell Shelton - Chief Executive Officer Robert Stefanovich - Chief Financial Officer Mark Sawicki - Chief Scientific Officer Thomas Heinzen - VP Investor Relations and Corporate Development Conference Call Participants ...
More CryoPort News

Company Profile

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Irvine, CA.

Head office United States
CEO Jerrell Shelton
Employees 1,170
Founded 1990
Website www.cryoport.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today